Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Asian Pacific Journal of Tropical Medicine ; 15(9):400-409, 2022.
Article in English | EMBASE | ID: covidwho-2080621

ABSTRACT

Objective: To evaluate long-term effects of COVID-19, and to determine the risk factors in long-COVID in a cohort of the Turkish Thoracic Society (TTS)-TURCOVID multicenter registry. Method(s): Thirteen centers participated with 831 patients;504 patients were enrolled after exclusions. The study was designed in three-steps: (1) Phone questionnaire;(2) retrospective evaluation of the medical records;(3) face-to-face visit. Result(s): In the first step, 93.5% of the patients were hospitalized;61.7% had a history of pneumonia at the time of diagnosis. A total of 27.1% reported clinical symptoms at the end of the first year. Dyspnea (17.00%), fatigue (6.30%), and weakness (5.00%) were the most prevalent long-term symptoms. The incidence of long-term symptoms was increased by 2.91 fold (95% CI 1.04-8.13, P=0.041) in the presence of chronic obstructive pulmonary disease and by 1.84 fold (95% CI 1.10-3.10, P=0.021) in the presence of pneumonia at initial diagnosis, 3.92 fold (95% Cl 2.29-6.72, P=0.001) of dyspnea and 1.69 fold (95% Cl 1.02-2.80, P=0.040) fatigue persists in the early-post-treatment period and 2.88 fold (95% Cl 1.52-5.46, P=0.001) in the presence of emergency service admission in the post COVID period. In step 2, retrospective analysis of 231 patients revealed that 1.4% of the chest X-rays had not significantly improved at the end of the first year, while computed tomography (CT) scan detected fibrosis in 3.4%. In step 3, 138 (27.4%) patients admitted to face-to-face visit at the end of first year;at least one symptom persisted in 49.27% patients. The most common symptoms were dyspnea (27.60%), psychiatric symptoms (18.10%), and fatigue (17.40%). Thorax CT revealed fibrosis in 2.4% patients. Conclusion(s): COVID-19 symptoms can last for extended lengths of time, and severity of the disease as well as the presence of comorbidities might contribute to increased risk. Long-term clinical issues should be regularly evaluated after COVID-19. Copyright © 2022 Asian Pacific Journal of Tropical Medicine Produced by Wolters Kluwer Medknow.

2.
Frontiers in Sustainable Cities ; 4, 2022.
Article in English | Scopus | ID: covidwho-2055105

ABSTRACT

Biodiversity loss is an important topic considering climate change, global warming, and even the reasoning of current and future animal-related diseases, such as the COVID-19 pandemic. Urban biodiversity is also important because of the ecosystem services they provide, restorative benefits for well-being, and physical health of the people who live in urban areas. Each city has its own strategies to cope with this issue, and these strategies do not function without the contribution of habitants of the cities. We developed an index (BBS) of the existing possibilities to support urban biodiversity in Berlin to measure the awareness and willingness of the Berliners to participate and support urban biodiversity. A survey was conducted in a face-to-face situation in four districts of Berlin with 431 urban residents, measuring preference for three different levels of biodiversity, connectedness to residential greenspace, neighborhood and city, nature relatedness, and willingness in participatory actions around greenspace. The results show that the high biodiversity condition in a photo scenario was preferred by most residents, indicating the appreciation for urban biodiversity. The connectedness to the residential greenspace was high (and higher than the connectedness to neighborhood and city), showing large potential for quality of life. While the overall willingness to participate in actions to support urban greenspace was rather high, our index shows substantial differences in activities, which are perceived more or less. This is a key result for urban park management to increase urban biodiversity participation processes. Copyright © 2022 Martens, Öztürk, Rindt, Twarok, Steinhardt and Molitor.

3.
The COVID-19 Pandemic in the Middle East and North Africa: Public Policy Responses ; : 159-185, 2022.
Article in English | Scopus | ID: covidwho-2055885
4.
Turk Geriatri Dergisi ; 25(1):042-048, 2022.
Article in English | EMBASE | ID: covidwho-1863653

ABSTRACT

Introduction: It is essential to comply with palliative care philosophy during consultations for hospitalisation purposes between specific medical branches and specialised palliative care services (SPCS). We aimed to evaluate the patients who were admitted or consulted to the palliative care service with a palliative care approach. Materials and Method: This descriptive study is based on retrospective review of data. The consultation requests delivered to the SPCS between December 1, 2019 and December 1, 2020 were evaluated through the hospital archive. The number of consultation requests delivered to the SPCS from other departments for hospitalisation purposes, demographic characteristics of patients, their acceptance and rejection rates, and reasons for which these decisions were made were examined. Results: Of the total 394 consultation requests, 53.6% (n = 211) were for males. The acceptance rate was 40.9% (n = 161). The most common primary diagnosis category was gastrointestinal cancers (21.6%), the most common consulting branch was emergency department (44.6%), the most common reason for rejection (53.2%) was the patient’s acute problems and the most common reason for acceptance was the need for nutritional support with a rate of 64.0%.Conclusion: It has been determined that most of the consultations requests were not accepted. It is necessary to use SPCS more effectively.

6.
Flora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisi ; 26(4):594-602, 2021.
Article in English | Web of Science | ID: covidwho-1622781

ABSTRACT

Introduction: As the pandemic continues, SARS-CoV-2 infection has inevitably been detected in patients hospitalized for other reasons. Detection of SARS-CoV-2 infected cases after hospitalization may lead to delay in taking appropriate infection control measures. Materials and Methods: The present study retrospectively scanned all electronic and hard copy records of the cases presented to the hospital and hospitalized for other reasons and then diagnosed as COV1D-19 in Suleyman Demirel University Faculty of Medicine, Research and Training Hospital between 01 April 2020 and 31 December 2020. Results: Accordingly, 22 cases were decided as community-acquired, 3 cases as probable community-acquired, 5 cases as hospital-acquired, and 4 cases as probable hospital-acquired. The reason for sampling for SARS-CoV-2 was determined as having symptoms compatible with COVID-19 in 23 (67.6%) of 34 cases, preoperative screening of COVID-19 infection in 9 (26.5%), and high risky contact in 2 cases (5.9%). Considering contact histories epidemiologically, it was thought that transmission occurred to 8 healthcare staff from 2 cases, and to other patients or relatives from 8 cases, but sequence analysis could not be performed. Conclusion: The high number of hospitalized patients diagnosed as COVID-19 creates a significant burden on the healthcare system in terms of infrastructure and management capacity. It is recommended that patients and healthcare professionals be screened widely and thoroughly, especially in conditions where COVID-19 cases are detected in non-COVID-1 9 units. This kind of screening will allow the potential outbreak to be controlled.

7.
Respiratory Case Reports ; 9(3):99-103, 2020.
Article in English | EMBASE | ID: covidwho-922924

ABSTRACT

After emerging in Wuhan city in December 2019, the coronavirus disease 2019 (COVID-19) rapidly spread throughout China. Although high rates of hospitalization are seen with COVID-19, no specific treatment has been reported, and the choice of antiviral therapies is limited. Favipiravir, approved in Japan for influenza, is one of the drugs that targets RNA-dependent RNA polymerase (RdRP). It significantly decreases the duration of fever, cough dyspnea, and the need of oxygen therapy or noninvasive mechanical ventilation, especially in moderate COVID-19 cases. In the current paper we presented four cases with worsening clinical conditions and the development of hypoxia who were treated with Favipiravir before being admitted to the intensive care unit, and who recovered from the disease.

SELECTION OF CITATIONS
SEARCH DETAIL